CGC
Price
$1.70
Change
+$0.33 (+24.09%)
Updated
Jun 6 closing price
Capitalization
784.64M
62 days until earnings call
HCM
Price
$15.35
Change
+$0.09 (+0.59%)
Updated
Jun 6 closing price
Capitalization
2.88B
58 days until earnings call
Interact to see
Advertisement

CGC vs HCM

Header iconCGC vs HCM Comparison
Open Charts CGC vs HCMBanner chart's image
Canopy Growth
Price$1.70
Change+$0.33 (+24.09%)
Volume$10.6M
Capitalization784.64M
HUTCHMED (China)
Price$15.35
Change+$0.09 (+0.59%)
Volume$60.61K
Capitalization2.88B
CGC vs HCM Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. HCM commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and HCM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CGC: $1.70 vs. HCM: $15.35)
Brand notoriety: CGC: Notable vs. HCM: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 139% vs. HCM: 69%
Market capitalization -- CGC: $784.64M vs. HCM: $2.88B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. HCM’s [@Pharmaceuticals: Other] market capitalization is $2.88B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 2 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • HCM’s FA Score: 2 green, 3 red.
According to our system of comparison, HCM is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while HCM’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • HCM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CGC is a better buy in the short-term than HCM.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а +28.79% price change this week, while HCM (@Pharmaceuticals: Other) price change was +10.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +78.59%. For the same industry, the average monthly price growth was +15.33%, and the average quarterly price growth was +66.92%.

Reported Earning Dates

CGC is expected to report earnings on Aug 08, 2025.

HCM is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+78.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($2.88B) has a higher market cap than CGC($785M). HCM YTD gains are higher at: 6.523 vs. CGC (-37.956). HCM has higher annual earnings (EBITDA): 67.3M vs. CGC (-1.02B). HCM has more cash in the bank: 886M vs. CGC (186M). HCM has less debt than CGC: HCM (86.1M) vs CGC (693M). HCM has higher revenues than CGC: HCM (838M) vs CGC (362M).
CGCHCMCGC / HCM
Capitalization785M2.88B27%
EBITDA-1.02B67.3M-1,519%
Gain YTD-37.9566.523-582%
P/E RatioN/A27.95-
Revenue362M838M43%
Total Cash186M886M21%
Total Debt693M86.1M805%
FUNDAMENTALS RATINGS
CGC vs HCM: Fundamental Ratings
CGC
HCM
OUTLOOK RATING
1..100
138
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9533
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCM's Valuation (89) in the Pharmaceuticals Major industry is in the same range as CGC (90) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's SMR Rating (33) in the Pharmaceuticals Major industry is somewhat better than the same rating for CGC (95) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew somewhat faster than CGC’s over the last 12 months.

HCM's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as CGC (64) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's P/E Growth Rating (5) in the Pharmaceuticals Major industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCHCM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACBYX14.900.09
+0.61%
American Beacon Balanced Y
VEMIX30.33N/A
N/A
Vanguard Emerging Mkts Stock Idx Instl
SPECX30.23N/A
N/A
Alger Spectra A
SBHVX14.02N/A
N/A
Segall Bryant & Hamill Sm Cp Val Ins
VCISX21.39N/A
N/A
Virtus KAR International Small-Mid Cap C